作者: Michael A. Pleiss , Jon D. Levine , Robert Owen Messing
DOI:
关键词:
摘要: The present invention relates to new AGC kinase inhibitors, in particular compounds of Formula I or II a stereoisomer, tautomer, racemic, metabolite, pro- pre-drug, salt, hydrate, solvate thereof, wherein Ar, Cy, R 1 , 3 p and n have the meaning defined claims. In particular, more specifically kinases compositions, pharmaceuticals, comprising such uses inhibitors treatment prophylaxis disease.